亚欧精品九九九,久久久45,久久中国日本

Novartis' Triple Phase III Study Success: Dual-Action Anti-BAFF-R Monoclonal Antibody Triumph Novartis Novartis' anti-BAFF-R antibody Ianalumab achieves breakthrough results in three Phase III trials for Sj?gren’s syndrome and immune thrombocytopenia, paving way for new autoimmune therapies.
Merck KGaA Lupus Drug Trial Update: Enpatoran Phase 2 Insights Merck Merck KGaA reveals detailed results from its phase 2 lupus trial of enpatoran, highlighting mixed outcomes in different patient cohorts and plans to pursue regulatory approval based on promising secondary endpoint data.
Cullinan Licenses $700M+ Autoimmune Drug from China Biotech Genrix Autoimmune Drug Cullinan Therapeutics signs a $700M+ licensing deal with China’s Genrix Bio for global rights to velinotamig, a bispecific T cell engager targeting autoimmune diseases, expanding its pipeline and global R&D strategy.
Competitive Landscape of Autoimmune Drug Development: Trends & Innovations Market Trend Explore the competitive landscape of autoimmune drug development, focusing on innovative therapies, treatment models, and global R&D trends driving progress in immune modulation and B cell depletion.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024 Autoimmune The autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水